BioXcel Therapeutics
BTAI
BTAI
36 hedge funds and large institutions have $32.6M invested in BioXcel Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+16
Holders Change %
+80%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
10
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$3.28M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$2.84M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$526K |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$662K |
| 5 |
5
Squarepoint
New York
|
$352K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SO
26
STRS Ohio
Columbus,
Ohio
| $17K | +$17K | +100 | New |
|
27
Bank of America
Charlotte,
North Carolina
| $14K | -$10.5K | -56 | -43% |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $11K | +$5.59K | +32 | +103% |
|
29
Legal & General Group
London,
United Kingdom
| $11K | +$11K | +63 | New |
|
|
AIP
30
Ameritas Investment Partners
Lincoln,
Nebraska
| $6K | +$6K | +33 | New |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $4K | +$4K | +24 | New |
|
32
Wells Fargo
San Francisco,
California
| $3K | -$409 | -3 | -12% |
|
|
GWM
33
Geneos Wealth Management
Englewood,
Colorado
| $2K | – | – | – |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1K | +6 | New |
|
35
BNP Paribas Financial Markets
Paris,
France
| $175 | +$175 | +1 | New |
|
36
Millennium Management
New York
| – | -$127K | -804 | Closed |
|
37
Nordea Investment Management
Stockholm,
Sweden
| – | -$1K | -6 | Closed |
|